Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents

Natural products and their analogs have been explored to stop the progression of cancer cells without unwanted side effects. Chalcones, compounds synthesized naturally in plants, have demonstrated potential as anti-cancer treatments. A library of bis-chalcones that are similar in structure to EF-24,...

Full description

Bibliographic Details
Main Authors: Smith Robert B., Roberts William, Upenieks Mary, Gibson Maya Z., Wentzel Michael T., Grice Kyle A., Zingales Sarah K.
Format: Article
Language:English
Published: De Gruyter 2023-04-01
Series:Heterocyclic Communications
Subjects:
Online Access:https://doi.org/10.1515/hc-2022-0162
_version_ 1797832450244608000
author Smith Robert B.
Roberts William
Upenieks Mary
Gibson Maya Z.
Wentzel Michael T.
Grice Kyle A.
Zingales Sarah K.
author_facet Smith Robert B.
Roberts William
Upenieks Mary
Gibson Maya Z.
Wentzel Michael T.
Grice Kyle A.
Zingales Sarah K.
author_sort Smith Robert B.
collection DOAJ
description Natural products and their analogs have been explored to stop the progression of cancer cells without unwanted side effects. Chalcones, compounds synthesized naturally in plants, have demonstrated potential as anti-cancer treatments. A library of bis-chalcones that are similar in structure to EF-24, a bis-chalcone molecule known to have anti-cancer properties, has been synthesized in order to examine their medicinal properties. This report highlights the synthesis of ten novel analogs, their anti-cancer activities, and conformational analysis via cryo-NMR and corroboration by density functional theory calculations of the lead compound 1b, tert-butyl 3,5-bis((E)-4-methylbenzylidene)-4-oxopiperidine-1-carboxylate.
first_indexed 2024-04-09T14:08:01Z
format Article
id doaj.art-c8f38322fa564bcd8995ac772be7d7b6
institution Directory Open Access Journal
issn 2191-0197
language English
last_indexed 2024-04-09T14:08:01Z
publishDate 2023-04-01
publisher De Gruyter
record_format Article
series Heterocyclic Communications
spelling doaj.art-c8f38322fa564bcd8995ac772be7d7b62023-05-06T15:58:55ZengDe GruyterHeterocyclic Communications2191-01972023-04-01291337680310.1515/hc-2022-0162Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agentsSmith Robert B.0Roberts William1Upenieks Mary2Gibson Maya Z.3Wentzel Michael T.4Grice Kyle A.5Zingales Sarah K.6Department of Chemistry, Georgia Southern University, Savannah, GA, 31419, USADepartment of Chemistry, University of Saint Joseph, West Hartford, CT, 06117, USADepartment of Chemistry, University of Saint Joseph, West Hartford, CT, 06117, USADepartment of Chemistry, Georgia Southern University, Savannah, GA, 31419, USADepartment of Chemistry, Augsburg University, Minneapolis, MN, 55454, USADepartment of Chemistry and Biochemistry, Depaul University, Chicago, IL, 60614, USADepartment of Chemistry, Georgia Southern University, Savannah, GA, 31419, USANatural products and their analogs have been explored to stop the progression of cancer cells without unwanted side effects. Chalcones, compounds synthesized naturally in plants, have demonstrated potential as anti-cancer treatments. A library of bis-chalcones that are similar in structure to EF-24, a bis-chalcone molecule known to have anti-cancer properties, has been synthesized in order to examine their medicinal properties. This report highlights the synthesis of ten novel analogs, their anti-cancer activities, and conformational analysis via cryo-NMR and corroboration by density functional theory calculations of the lead compound 1b, tert-butyl 3,5-bis((E)-4-methylbenzylidene)-4-oxopiperidine-1-carboxylate.https://doi.org/10.1515/hc-2022-0162bis-chalconecurcuminanti-cancerdynamic nmrdft
spellingShingle Smith Robert B.
Roberts William
Upenieks Mary
Gibson Maya Z.
Wentzel Michael T.
Grice Kyle A.
Zingales Sarah K.
Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents
Heterocyclic Communications
bis-chalcone
curcumin
anti-cancer
dynamic nmr
dft
title Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents
title_full Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents
title_fullStr Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents
title_full_unstemmed Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents
title_short Synthesis and conformational analysis of N-BOC-protected-3,5-bis(arylidene)-4-piperidone EF-24 analogs as anti-cancer agents
title_sort synthesis and conformational analysis of n boc protected 3 5 bis arylidene 4 piperidone ef 24 analogs as anti cancer agents
topic bis-chalcone
curcumin
anti-cancer
dynamic nmr
dft
url https://doi.org/10.1515/hc-2022-0162
work_keys_str_mv AT smithrobertb synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents
AT robertswilliam synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents
AT upenieksmary synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents
AT gibsonmayaz synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents
AT wentzelmichaelt synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents
AT gricekylea synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents
AT zingalessarahk synthesisandconformationalanalysisofnbocprotected35bisarylidene4piperidoneef24analogsasanticanceragents